- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Keratoconic Subjects in Taiwan
Total 18 results
-
National Taiwan University HospitalNational Science Council, TaiwanCompletedHealthy SubjectsTaiwan
-
Taipei Veterans General Hospital, TaiwanNational Science Council, TaiwanCompleted
-
Ming-Tsang WuCompleted
-
National Taiwan University HospitalNational Science Council, TaiwanCompleted
-
isRed Pharma & Biotech Research CorporationYung Shin Pharmaceutical Ind. Co., Ltd.Unknown
-
National Taiwan University HospitalUnknownHealthy Subjects | EEG Data AnalysisTaiwan
-
Taipei Medical University WanFang HospitalTaipei Medical UniversityCompletedHealthy Subjects | Health Care ProvidersTaiwan
-
National Taiwan University HospitalUnknownHealthy Subjects With Different ConstitutionsTaiwan
-
Yung Shin Pharm. Ind. Co., Ltd.Taichung Veterans General HospitalCompletedPharmacokinetic of Tenofovir in Healthy SubjectsTaiwan
-
National Taiwan University HospitalUnknownRheumatoid Arthritis | Healthy Subjects | SLETaiwan
-
Taipei Medical University WanFang HospitalUnknownHealthy SubjectsTaiwan
-
Chung Shan Medical UniversityNot yet recruitingPharmacokinetic Effect of AstraGin on Whey Protein Absorption and Muscle Function in Healthy SubjectsTaiwan
-
National Taiwan University HospitalUnknownKeratoconus | Ocular Surface Disease | Irregular AstigmatismTaiwan
-
Buddhist Tzu Chi General HospitalCompletedFunctional Gastrointestinal Disorders | Healthy SubjectsTaiwan
-
National Taiwan University HospitalUnknownAbdominal Obesity Metabolic Syndrome | Subjects With Poor Fitness StatusTaiwan
-
Buddhist Tzu Chi General HospitalCompletedIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Healthy Subjects | COVID-19 PneumoniaTaiwan
-
Buddhist Tzu Chi General HospitalRecruitingIrritable Bowel Syndrome | Functional Gastrointestinal Disorders | Healthy Subjects | Laryngopharyngeal RefluxTaiwan
-
Lotus PharmaceuticalUnknownThe Objectives of the Study is to Evaluate the Efficacy and Safety of Acarmet (Metformin HCl 500 mg | Plus Acarbose 50 mg Tablets) Thrice Daily Versus Acarbose 50 mg Thrice Daily Over 16 Weeks in | Subjects With Type 2 Diabetes Mellitus.Taiwan